Use of piperazine sulfonic acid derivatives as CCR1 antagonists for the treatment of fibrosis, alzheimer disease and other disorders
A Standard patent application filed on 20 October 2003 credited to Gaweco, Anderson See ; Gladue, Ronald Paul ; Hayward, Matthew Merrill ; Brown, Matthew Frank

Details

Application number :

2003269381  

Application type :

Standard  

Application status :

LAPSED  

Under opposition :

No  

Proceeding type :

 

Invention title :

Use of piperazine sulfonic acid derivatives as CCR1 antagonists for the treatment of fibrosis, alzheimer disease and other disorders  

Inventor :

Gaweco, Anderson See ; Gladue, Ronald Paul ; Hayward, Matthew Merrill ; Brown, Matthew Frank  

Agent name :

Spruson & Ferguson  

Address for service :

Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 Australia  

Filing date :

20 October 2003  

Associated companies :

 

Applicant name :

Pfizer Products Inc.  

Applicant address :

Eastern Point Road Groton CT 06340 United States of America  

Old name :

 

Original Source :

Go  

Same Inventor

• Use of piperazine derivatives as ccr1 antagonists